[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 882
Citations 0
Invited Commentary
November 2016

Pharmaceutical Industry Interactions With Nonprescribing CliniciansA Complex Web of Influence

Author Affiliations
  • 1MGH Institute of Health Professions, Boston, Massachusetts
JAMA Intern Med. 2016;176(11):1720-1721. doi:10.1001/jamainternmed.2016.5284

Grundy and colleagues1 have elegantly quantified a practice that has garnered scant attention in the literature; that is, that pharmaceutical promotions reach well beyond the bounds of physicians and even other authorized prescribers, such as nurse practitioners (NPs). The findings that nonprescribing nurses were present at nearly 40% of pharmaceutical company–sponsored educational events in Australia between 2011 and 2015 were noteworthy, yet not at all surprising.

First Page Preview View Large
First page PDF preview
First page PDF preview